Cite
Asymptomatic nonspecific serum hyperamylasemia and hyperlipasemia: spectrum of MRCP findings and clinical implications
MLA
Koenraad J. Mortele, et al. “Asymptomatic Nonspecific Serum Hyperamylasemia and Hyperlipasemia: Spectrum of MRCP Findings and Clinical Implications.” Abdominal Imaging, vol. 29, Oct. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8966f306b52c62a8317028ed2fac6d1f&authtype=sso&custid=ns315887.
APA
Koenraad J. Mortele, Pablo R. Ros, Kelly H. Zou, Stuart G. Silverman, & Walter Wiesner. (2003). Asymptomatic nonspecific serum hyperamylasemia and hyperlipasemia: spectrum of MRCP findings and clinical implications. Abdominal Imaging, 29.
Chicago
Koenraad J. Mortele, Pablo R. Ros, Kelly H. Zou, Stuart G. Silverman, and Walter Wiesner. 2003. “Asymptomatic Nonspecific Serum Hyperamylasemia and Hyperlipasemia: Spectrum of MRCP Findings and Clinical Implications.” Abdominal Imaging 29 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8966f306b52c62a8317028ed2fac6d1f&authtype=sso&custid=ns315887.